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Background: Despite the increasing use of atherectomy, few studies have compared
outcomes of endovascular procedures performed in an outpatient ofﬁce-based labo-
ratory (OBL) to those performed in the traditional hospital setting. As the trend for
increased outpatient treatment continues, it is critical to begin to assess the procedural
outcomes of atherectomy in the OBL setting.
Methods: We analyzed the CONFIRM registry series, a data collection of patients
with peripheral arterial disease (PAD) who were treated with orbital atherectomy in
both the OBL and hospital settings.
Results: We found that 36% of patients in both the hospital and OBL groups were
classiﬁed as Rutherford class 3 (p¼0.96) and the lesions treated were moderately to
severely calciﬁed (angiographic evaluation) in 83% and 90% of hospital and OBL
setting, respectively (p¼0.07). Final residual stenosis, after adjunctive therapy, was 10
 11% in the hospital group and 11  17% in the OBL group (p¼0.32). Dissections,
including ﬂow limiting and non-ﬂow limiting, occurred in 11.4% of lesions in the
hospital group vs. 6.5% in the OBL group (p¼0.12). Adjusted logistic regressions
showed no difference in any individual complication rate or the overall complication
rate.
Conclusions: Orbital atherectomy treatment of PAD in an ofﬁce-based laboratory
was found to be comparable to treatment in a hospital setting. Due to the emergence of
more ofﬁce-based laboratories utilizing orbital atherectomy, a follow-up prospective
study is warranted to further investigate the comparative outcomes within a larger
patient population.
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Introduction: Intravascular ultrasound (IVUS) is used in infrainguinal vessels in a
variety of fashions, the results of which are not well understood in terms of improving
procedure efﬁciency and reducing complications.
Methods: We retrospectively selected 38 endovascular procedures between 2007 and
2013 from the Excellence in Peripheral Arterial Disease (XLPAD) registry that uti-
lized IVUS in the superﬁcial femoral artery and/or popliteal artery. We matched this
cohort with a random sample of 38 procedures from the XLPAD registry to achieve
non-signiﬁcant differences in lesion complexity and presenting symptoms. The in-
dications for IVUS use were categorized, and comparisons were made to assess for
signiﬁcant differences in procedure duration, contrast volume, ﬂuoroscopy time, dose
area product radiation exposure, and procedure complications.
Results: Use of IVUS was mainly to diagnose lesion complexity prior to crossing
(n¼10, 26.3%) and to conﬁrm intraluminal position after crossing (n¼11, 28.9%).
IVUS was associated with longer procedure times (180.2  53.1 min vs. 144.1  54.1
min; p¼0.008), but without signiﬁcant differences in procedure complications (2.6%
vs. 7.9%; p¼0.615), ﬂuoroscopy time (44.6  21.4 min vs. 39.0  22.4 min;
p¼0.277), radiation exposure (251.3  139.9 Gy-cm2 vs. 247.1  137.2 Gy-cm2;
p¼0.903), and contrast volume (215.4  88.5 mL vs. 197.0  87.5 mL; p¼0.367).
Conclusion: IVUS is mostly used to aid in crossing the long, complex infrainguinal
lesions, and is associated with longer procedure times without losing efﬁciency or
increasing complications.CRT-211
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Background: At presentation, females with peripheral arterial disease (PAD) are
older, have smaller vessels, and additional comorbidities, all contributing to more
severe disease. Compared with males, females have marginally worse outcomes
including limb salvage, morbidity, and mortality after lower extremity revascularization
procedures. Female gender may be associated with an increased risk of adverse events
after endovascular treatment of PAD.
Methods: CONFIRM I, II, and III are large, multi-center, non-randomized, all-
comers registries of over 3,000 patients with PAD who were treated in the U.S. with
the Orbital Atherectomy System (OAS) (Cardiovascular Systems, Inc., St. Paul, MN).
In the CONFIRM series, 60% of patients were male compared to 40% female. This
analysis compared the ﬁnal residual stenosis achieved after treatment with OAS as well
as the rate of acute procedural complications in female and male patients in the
CONFIRM series.
Results: Females were older (73.2  10.7 vs. 70.4  10.2, p<0.001) and had a trend
towards higher prevalence of critical limb ischemia (Rutherford Categories 4-6: 46%
vs. 42%, p¼0.075). The ﬁnal percent stenosis in females and males was 9%  11% and
11%  11%, respectively (p<0.001). Females had a higher rate of total dissection,
including ﬂow-limiting, non-ﬂow limiting, and unknown type (13.3% vs. 9.9%,
p<0.001). However, females and males had similar rates of ﬂow-limiting dissection
(1.6% vs. 1.4%, p¼0.62). Females and males had similar rates of perforation (0.8% vs.
0.7%, p¼0.57), slow ﬂow (4.4% vs. 4.5%, p¼0.96), vessel closure (1.8% vs. 1.2%,
p¼0.11), spasm (6.8% vs. 6.0%, p¼0.24) and thrombus formation (1.3% vs. 1.2%,
p¼0.74). Females had a trend towards increased embolism (2.8% vs. 1.9%, p¼0.07).
Conclusion: The gender analysis of the CONFIRM registries revealed that there was
successful lesion modiﬁcation with orbital atherectomy in both female and male pa-
tients; however, females had a higher rate of dissection (all types). This difference is
likely due to the older age and higher percentage of critical limb ischemia in females
versus males in this study. These results, however, suggest that additional studies
should be completed to further understand the increased risks for females versus males
during endovascular procedures.
